Here I am again. Disappointingly struggling to find a suitable option for taking up arms to defeat this thing.
This week I met Susanna Banerjee of the Royal Marsden to discuss possible trials on offer for the likes of me.
BRCA1 positive, yet now classified as PARP resistant. It was good hearing this from the horses mouth as Dr Banerjee has been overseeing most of the trials of all the PARPS, from Olaparib, Niraparib, etc.
She is positive that neither a stronger dose, nor changing to a different PARP, will prove to be effective for me.
My choices right now, are to go on weekly Taxol at my beloved local RUH, or take the DICE trial, which would either be weekly Taxol combined with a targeted drug called TAK228, or plain old weekly Taxol.
It’s a randomised study, but pretty easy to know which arm you are on, as the TAK228 is given as tablets.
I still am holding out for a second surgery, but my Scan results will not be available until next Thursday, when I will see my Oncologist to discuss my options. If I get no joy from my local surgeon, I will try to get a speedy referral to Christine Fotopoulou.
I am now off the Niraparib, so I have no safeguards in place to stop a speedier progression. So I hope a decision comes through quickly.
My questions:
Anyone else joining the DICE trial?
Any other BRCA1 or 2 ladies found to be PARP resistant?
Thanks for listening,
Laura